N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide
C25H27F3N4O2 — CID 166629452
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide
N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide (PubChem CID 166629452) has the molecular formula C25H27F3N4O2 and a molecular weight of 472.51 g/mol. Its IUPAC name is N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide.
Molecular Properties
| Compound Name | N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide |
|---|---|
| PubChem CID | 166629452 |
| Molecular Formula | C25H27F3N4O2 |
| Molecular Weight | 472.51 g/mol |
| Exact Mass | 472.21 |
| IUPAC Name | N-(6-methoxy-1,5-naphthyridin-4-yl)-4-methyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]piperidine-4-carboxamide |
| SMILES | COc1ccc2nccc(NC(=O)C3(C)CCN(CCc4ccc(C(F)(F)F)cc4)CC3)c2n1 |
| InChI | InChI=1S/C25H27F3N4O2/c1-24(23(33)30-20-9-13-29-19-7-8-21(34-2)31-22(19)20)11-15-32(16-12-24)14-10-17-3-5-18(6-4-17)25(26,27)28/h3-9,13H,10-12,14-16H2,1-2H3,(H,29,30,33) |
| InChIKey | VSQIBXDZBCQBDN-UHFFFAOYSA-N |
| XLogP | 4.94 |
| TPSA | 67.35 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.51 |
| LogP ≤ 5 | 4.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166629452 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.